Erasca, Inc. (ERAS)
Data as of , from SEC Form 4 filings.
See up to 3 months of ERAS. The 7-day demo opens the 1M and 3M ranges and puts ERAS on your watchlist.
Start 7-day demoLatest ERAS insider trades
- Ebun Garner - OfficerOpen-market sale$1.31M
Shannon Morris - OfficerOpen-market sale$301K- Ebun Garner - Officer
About Erasca, Inc. (ERAS)
Erasca, Inc. is an SEC registrant, filing under CIK 0001761918, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
ERAS Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 1,300,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
ERAS insider transactions (Form 4)
2921 Form 4 filings on record, the earliest from Jun 24, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Charles S. Fuchs - Officer | Grant or award | Stock option (right to buy) | 1,300,000 footnote F1 | $0.00 | - | |
| ||||||
 Valerie Denise Harding Start | Grant or award | Stock option (right to buy) | 29,888 | $0.00 | - | |
| Jean I. Liu | Grant or award | Stock option (right to buy) | 29,888 | $0.00 | - | |
| Pratik S. Multani | Grant or award | Stock option (right to buy) | 29,888 | $0.00 | - | |
 Alexander W. Casdin | Grant or award | Stock option (right to buy) | 29,888 | $0.00 | - | |
| Julie Hambleton | Grant or award | Stock option (right to buy) | 29,888 | $0.00 | - | |
| James Arthur Bristol | Grant or award | Stock option (right to buy) | 29,888 | $0.00 | - | |
| Ebun Garner - Officer | Option exercise | Common Stock | 80,000 | $1.70 | $136K | |
| Ebun Garner - Officer | Open-market sale | Common Stock | 80,000 | $16.40 footnote F2 | $1.31M | |
| Ebun Garner - Officer | Option exercise | Stock Option (right to buy) | 80,000 | $0.00 | - | |
| ||||||
| Shannon Morris - Officer | Option exercise | Common Stock | 20,000 | $1.70 | $34K | |
| Shannon Morris - Officer | Open-market sale | Common Stock | 20,000 | $15.04 footnote F2 | $301K | |
| Shannon Morris - Officer | Option exercise | Stock Option (right to buy) | 20,000 | $0.00 | - | |
| ||||||
 Jonathan E. Lim - Officer | Grant or award | Stock option (right to buy) | 2,000,000 | $0.00 | - | |
| David M. Chacko - Officer | Other | Common Stock | 17,793 | $1.19 footnote F2 | $21K | |
| David M. Chacko - Officer | Grant or award | Stock option (right to buy) | 640,000 | $0.00 | - | |
| ||||||
| Shannon Morris - Officer | Grant or award | Stock option (right to buy) | 625,000 | $0.00 | - | |
| Michael David Varney | Grant or award | Stock option (right to buy) | 96,000 | $0.00 | - | |
| Ebun Garner - Officer | Grant or award | Stock option (right to buy) | 560,000 | $0.00 | - | |
| Ebun Garner - Officer | Grant or award | Common Stock | 3,902 | $1.19 footnote F1 | $5K | |
| Ebun Garner - Officer | Option exercise | Common Stock | 120,000 | $1.70 | $204K | |
| Ebun Garner - Officer | Open-market sale | Common Stock | 120,000 | $5.59 footnote F3 | $671K | |
| Ebun Garner - Officer | Option exercise | Stock Option (right to buy) | 120,000 | $0.00 | - | |
| ||||||
| James Arthur Bristol | Grant or award | Stock Option (right to buy) | 37,762 | $0.00 | - | |
| Jean I. Liu | Grant or award | Stock Option (right to buy) | 20,617 | $0.00 | - | |
| Pratik S. Multani | Grant or award | Stock Option (right to buy) | 19,532 | $0.00 | - | |
| Valerie Denise Harding Start | Grant or award | Stock Option (right to buy) | 24,306 | $0.00 | - | |
| Alexander W. Casdin | Grant or award | Stock Option (right to buy) | 23,872 | $0.00 | - | |
| Jean I. Liu | Grant or award | Stock option (right to buy) | 120,000 | $0.00 | - | |
Recent ERAS Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Erasca Foundation | Foundation | 8,333 | $133K | View on EDGAR | |
| Erasca Foundation | Foundation | 8,333 |
ERAS insider trading FAQ
What is the latest insider trade for ERAS?
Erasca, Inc. (ERAS) had 1 insider filing in the last 90 days, with the most recent on 2026-08-12. The full record for ERAS runs to 21 Form 4 filings, the earliest from 2025-06-24. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ERAS stock?
No insider purchases of ERAS were filed in the last 90 days.
How many insiders are selling ERAS stock?
No insider sales of ERAS were filed in the last 90 days. 3 sales are on record for this company.
Where can I see ERAS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ERAS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Charles S. Fuchs view on EDGAR
- - Valerie Denise Harding Start view on EDGAR
- - Jean I. Liu view on EDGAR
- - Pratik S. Multani view on EDGAR
- - Alexander W. Casdin view on EDGAR
- - Julie Hambleton view on EDGAR
- - James Arthur Bristol view on EDGAR
- - Ebun Garner view on EDGAR
- - Shannon Morris view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ERAS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ERAS with a 7-day demo
- ERAS on your watchlist
- Every ERAS Form 4 filing on record
- Up to 3 months of ERAS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
